What is the relationship between the health yuan of Livzon Group of Anshi Pharmaceutical?

Health Yuan is the controlling shareholder of Livzon Group, and Anshi seems to have nothing to do with them.

The first phase of Anshi Pharmaceutical (Zhongshan) Co., Ltd. covers an area of more than 20,000 square meters, and has built a solid preparation workshop, a powder injection sub-packaging workshop, a freeze-dried powder injection workshop and a quality inspection center.

Livzon Pharmaceutical Group Co., Ltd. is a comprehensive enterprise group integrating pharmaceutical R&D, production and sales. Founded in1985,65438+10, it connects Hong Kong by water and Macau by land. According to the two-hour drive from Guangzhou and Shenzhen, the location advantage is obvious. The registered capital of the company is 306 million yuan, which is a privately-held listed company. Livzon Group completed the shareholding system reform on 1993 and became the first A-share and B-share listed company in the national pharmaceutical industry. The Group has 12 wholly-owned subsidiaries and 10 holding enterprises with 5,000 employees. Employees with college education or above account for 83% of the total number of the group. The enterprise has strong technical force, excellent equipment and advanced technology, and its production level and quality level are in the leading position in the industry. The 53 production lines of the Group passed GMP certification and acceptance, and the marketing enterprises successfully passed the national GSP certification, and their marketing power was significantly enhanced. Livzon Pharmaceutical Group has established a marketing network covering the domestic market, and established stable and good business relations with major commercial channels and thousands of hospitals. With the continuous improvement of the quality system, the rapid growth of sales, the continuous expansion of production capacity and the acceleration of the construction of new factories, Livzon Group will become a leading domestic and world-class modern pharmaceutical leading enterprise. On March 6, 20 14, Zhuhai Livzon McAb Biotechnology Co., Ltd., a joint venture subsidiary of Livzon Group and Healthy Yuan, obtained the approval number of the national (SFDA) for recombinant humanized anti-tumor necrosis factor α monoclonal antibody for injection.

Healthy Yuan Pharmaceutical Group Co., Ltd. was born on September 29th, 2003. The group, formerly known as Taitai Pharmaceutical Co., Ltd., is a large pharmaceutical enterprise established in 1992 12 18, and successfully listed on the Shanghai Stock Exchange on 200 1. At present, Health Yuan Pharmaceutical Group has developed into a specialized comprehensive pharmaceutical enterprise covering four major fields: raw materials, OTC, prescription drugs and health care products.